Cargando…
Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block
Human-based modelling and simulations are becoming ubiquitous in biomedical science due to their ability to augment experimental and clinical investigations. Cardiac electrophysiology is one of the most advanced areas, with cardiac modelling and simulation being considered for virtual testing of pha...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970534/ https://www.ncbi.nlm.nih.gov/pubmed/31868580 http://dx.doi.org/10.7554/eLife.48890 |
_version_ | 1783489540018667520 |
---|---|
author | Tomek, Jakub Bueno-Orovio, Alfonso Passini, Elisa Zhou, Xin Minchole, Ana Britton, Oliver Bartolucci, Chiara Severi, Stefano Shrier, Alvin Virag, Laszlo Varro, Andras Rodriguez, Blanca |
author_facet | Tomek, Jakub Bueno-Orovio, Alfonso Passini, Elisa Zhou, Xin Minchole, Ana Britton, Oliver Bartolucci, Chiara Severi, Stefano Shrier, Alvin Virag, Laszlo Varro, Andras Rodriguez, Blanca |
author_sort | Tomek, Jakub |
collection | PubMed |
description | Human-based modelling and simulations are becoming ubiquitous in biomedical science due to their ability to augment experimental and clinical investigations. Cardiac electrophysiology is one of the most advanced areas, with cardiac modelling and simulation being considered for virtual testing of pharmacological therapies and medical devices. Current models present inconsistencies with experimental data, which limit further progress. In this study, we present the design, development, calibration and independent validation of a human-based ventricular model (ToR-ORd) for simulations of electrophysiology and excitation-contraction coupling, from ionic to whole-organ dynamics, including the electrocardiogram. Validation based on substantial multiscale simulations supports the credibility of the ToR-ORd model under healthy and key disease conditions, as well as drug blockade. In addition, the process uncovers new theoretical insights into the biophysical properties of the L-type calcium current, which are critical for sodium and calcium dynamics. These insights enable the reformulation of L-type calcium current, as well as replacement of the hERG current model. |
format | Online Article Text |
id | pubmed-6970534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-69705342020-01-22 Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block Tomek, Jakub Bueno-Orovio, Alfonso Passini, Elisa Zhou, Xin Minchole, Ana Britton, Oliver Bartolucci, Chiara Severi, Stefano Shrier, Alvin Virag, Laszlo Varro, Andras Rodriguez, Blanca eLife Cell Biology Human-based modelling and simulations are becoming ubiquitous in biomedical science due to their ability to augment experimental and clinical investigations. Cardiac electrophysiology is one of the most advanced areas, with cardiac modelling and simulation being considered for virtual testing of pharmacological therapies and medical devices. Current models present inconsistencies with experimental data, which limit further progress. In this study, we present the design, development, calibration and independent validation of a human-based ventricular model (ToR-ORd) for simulations of electrophysiology and excitation-contraction coupling, from ionic to whole-organ dynamics, including the electrocardiogram. Validation based on substantial multiscale simulations supports the credibility of the ToR-ORd model under healthy and key disease conditions, as well as drug blockade. In addition, the process uncovers new theoretical insights into the biophysical properties of the L-type calcium current, which are critical for sodium and calcium dynamics. These insights enable the reformulation of L-type calcium current, as well as replacement of the hERG current model. eLife Sciences Publications, Ltd 2019-12-24 /pmc/articles/PMC6970534/ /pubmed/31868580 http://dx.doi.org/10.7554/eLife.48890 Text en © 2019, Tomek et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cell Biology Tomek, Jakub Bueno-Orovio, Alfonso Passini, Elisa Zhou, Xin Minchole, Ana Britton, Oliver Bartolucci, Chiara Severi, Stefano Shrier, Alvin Virag, Laszlo Varro, Andras Rodriguez, Blanca Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block |
title | Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block |
title_full | Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block |
title_fullStr | Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block |
title_full_unstemmed | Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block |
title_short | Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block |
title_sort | development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block |
topic | Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970534/ https://www.ncbi.nlm.nih.gov/pubmed/31868580 http://dx.doi.org/10.7554/eLife.48890 |
work_keys_str_mv | AT tomekjakub developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT buenoorovioalfonso developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT passinielisa developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT zhouxin developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT mincholeana developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT brittonoliver developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT bartoluccichiara developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT severistefano developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT shrieralvin developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT viraglaszlo developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT varroandras developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock AT rodriguezblanca developmentcalibrationandvalidationofanovelhumanventricularmyocytemodelinhealthdiseaseanddrugblock |